| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > PR > More Public Relations Advice from the PR Doctor |
|
Just Other Articles - More Public Relations Advice from the PR Doctor
The reputation of a company or organization is an intangible asset, but it is an extremely important and v According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product aluable asset. Some people believe and have written that a good reputation is an organization's most price ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ess asset. Unfortunately businesses face inevitable crisis situations with the potential to seriously dama lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e a good reputation. One may ask what can be done to establish a good reputation, keep that good reputati here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe on and when hit by a crisis, repair a damaged reputation? Is there a prescription out there that provides d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ome solid advice on this subject? Well, the “PR Doctor” researched the subject and was referred to a book ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ntitled “The 18 Immutable Laws of Corporate Reputation. Creating, Protecting and Repairing Your Most Valua easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ble Asset,” and authored by Ronald J. Alsop. Mr. Alsop provides information on “lessons learned” from rea nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically world company and organization crises and provides a roadmap with his 18 Immutable Laws. He breaks those and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ 8 laws into 3 parts. Part 1 is about establishing a good reputation. Part 2 deals with keeping that good r ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi putation and then Part 3 presents information on repairing a damaged reputation. Part 1 - Establishing A ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Good Reputation Law One: Maximize Your Most Powerful Asset_ Law Two: Know Thyself - Measure Your Reputati dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod n Law Three: Learn to Play to Many Audiences_ Law Four: Live Your Values and Ethics Law Five: Be a Model cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin itizen_ Law Six: Convey a Compelling Corporate Vision_ Law Seven: Create Emotional Appeal Part 2 - Keepi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ng A Good Reputation Law Eight: Recognize Your Shortcomings Law Nine: Stay Vigilant Law Ten: Make Your Emp t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel oyees Your Reputation Champions Law Eleven: Control the Internet Before It Controls You Law Twelve: Speak ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ith a Single Voice Law Thirteen: Beware the Dangers of Reputation Rub-off Part 3 - Repairing A Damaged Rep y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products utation Law Fourteen: Manage Crises with Finesse Law Fifteen: Fix It Right the First Time Law Sixteen: Nev . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r Underestimate the Public's Cynicism Law Seventeen: Remember - Being Defensive Is Offensive Law Eighteen: elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip If All Else Fails, Change Your Name For a good summary of each of the 18 laws, please go to: www.bizsum.co tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Qualities of A Professional Commanding eCommerce with National Wholesale Liquidators A Great Marketing Model - Utilizing the Power of OPM
|